- Home
- A-Z Publications
- Current Drug Safety
- Previous Issues
- Volume 8, Issue 3, 2013
Current Drug Safety - Volume 8, Issue 3, 2013
Volume 8, Issue 3, 2013
-
-
Annual Trends in Use of Periconceptional Folic Acid and Birth Prevalence of Major Congenital Malformations
Authors: Audrey-Ann Richard-Tremblay, Odile Sheehy and Anick BerardBackground: Recent evidence suggests that periconceptional folic acid use could not only prevent neural tube defects but also other malformations. The objectives of this study were to assess trends in dispensed high dose periconceptional folic acid (5 mg) and birth prevalence of major congenital malformations. Methods: The Quebec Pregnancy Registry, an administrative database with information on periconcept Read More
-
-
-
Adverse Drug Reaction Labelling for Atomoxetine, Methylphenidate and Modafinil: Comparison of Product Information for Oral Formulations in Australia, Denmark and the United States
Authors: Lise Aagaard and Ebba Holme HansenMedical product information contains information about efficacy and safety for marketed pharmaceuticals. Three studies have compared safety labelling for different therapeutic categories in different countries and detected large variations in a number of reported adverse drug reactions (ADRs). The rapid increase in use of medications for treatment of ADHD symptoms has created concern due to lack of information abou Read More
-
-
-
A Systematic Review of the Efficacy and Safety of Desipramine for Treating ADHD
More LessThis review article systematically and critically summarizes the current evidence regarding desipramine for treating children and adolescents with attention deficit hyperactivity disorder (ADHD). PRISMA guideline was used for gathering the data. The databases of PubMed/Medline and Google scholar were electronically searched. This review included controlled clinical trials investigating the efficacy of desipramine for treating c Read More
-
-
-
Hyponatraemia: An Audit of Aged Psychiatry Patients Taking SSRIs and SNRIs
Authors: Francesco Giorlando, Julia Teister, Seetal Dodd, Marc Udina and Michael BerkObjective: Hyponatraemia is a serious adverse event commonly reported in elderly people treated with serotonergic antidepressants. The mechanism, incidence and risk factors for antidepressant induced hyponatraemia are not fully understood. Method: In a retrospective chart analysis, depressed patients aged >63 years were investigated for change in serum sodium levels between two time points, separated b Read More
-
-
-
Risk Factors for Serious Adverse Effects of Thiopurines in Patients with Crohn’s Disease
Authors: Yoav Mazor, Eduard Koifman, Hela Elkin, Yehuda Chowers, Norberto Krivoy, Amir Karban and Edna EfratiPurpose: Thiopurines are effective in attaining and maintaining remission in patients with inflammatory bowel diseases (IBD). The major drawback of these drugs are their serious adverse effects (SAE), highlighting the importance of preemptive identification of patients at risk. We aimed to examine whether gene polymorphisms in GSTM1, GSTT1 and TPMT, combined with various clinical parameters, can predict thiopurine in Read More
-
-
-
Safety of Inhaled Fluticasone Propionate Therapy for Pediatric Asthma - A Systematic Review
Authors: Prasad Muley, Monali Shah and Arti MuleyContext and Aim: Asthma is a common problem in paediatric population. International treatment guidelines recognize the role of inhaled corticosteroids for asthma in young children. Inhaled fluticasone propionate is reported to have greater systemic effects like other corticosteroids. Limited data is available on safety of this drug when used for longer duration. So, we conducted a systematic review to study the effect Read More
-
-
-
Metronidazole Induced DNA Damage in Somatic Cells of Drosophila melanogaster
Authors: Ana M. Palermo and Marta Dolores MudryThe standard version of the wing somatic mutation and recombination test (SMART) in Drosophila melanogaster was employed in order to evaluate the genotoxic potential of metronidazole (MTZ) as a function of exposure concentration. MTZ was administered by chronic feeding of 3-day-old larvae with the parenteral solution at 0, 500, 1000 and 2000 µg/ml until pupation. The marker-heterozygous progeny (mwh+/+flr3) with Read More
-
-
-
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis
Levofloxacin induced psychiatric adverse effects are rare, although they can be serious. There are just five cases of fluoroquinolone-induced delirium published in the medical literature. To our best knowledge, none of them occurred in psychotic patients. We report a case of a 38-year-old Caucasian man diagnosed with schizoaffective disorder and multiple sclerosis who developed delirium and visual hallucinations after initi Read More
-
-
-
Severe Toxic Hepatitis Associated with Dronedarone
Authors: Stephan Jahn, Gernot Zollner, Carolin Lackner and Rudolf E. StauberDronedarone was introduced in 2009 as a new antiarrhythmic agent and since then has been increasingly prescribed in atrial fibrillation or flutter. To date, two cases of severe toxic hepatitis have been reported in patients treated with dronedarone, both requiring emergency liver transplantation, and the FDA as well as the EMA have issued warnings about possible severe hepatotoxicity of dronedarone. Here we re Read More
-
-
-
Missed Paracetamol (Acetaminophen) Overdose Due to Confusion Regarding Drug Names
Authors: David G. Hewett, Jennifer Shields and W. Stephen WaringImmediate management of drug overdose relies upon the patient account of what was ingested and how much. Paracetamol (acetaminophen) is involved in around 40% of intentional overdose episodes, and remains the leading cause of acute liver failure in many countries including the United Kingdom. In recent years, consumers have had increasing access to medications supplied by international retailers via the intern Read More
-
-
-
Liver Injury Associated with Antidepressants
Authors: Susie H. Park and Risa IshinoAntidepressants are commonly prescribed and used in the management of depression, anxiety disorders, and other psychiatric illnesses. Antidepressants used in therapeutic dosing ranges are associated with causing several adverse drug reactions including hepatotoxicity. Paroxetine, fluoxetine, fluvoxamine, citalopram, mirtazapine and venlafaxine are associated with reversible liver injury upon discontinuation of the a Read More
-
Volumes & issues
-
Volume 20 (2025)
-
Volume 19 (2024)
-
Volume 18 (2023)
-
Volume 17 (2022)
-
Volume 16 (2021)
-
Volume 15 (2020)
-
Volume 14 (2019)
-
Volume 13 (2018)
-
Volume 12 (2017)
-
Volume 11 (2016)
-
Volume 10 (2015)
-
Volume 9 (2014)
-
Volume 8 (2013)
-
Volume 7 (2012)
-
Volume 6 (2011)
-
Volume 5 (2010)
-
Volume 4 (2009)
-
Volume 3 (2008)
-
Volume 2 (2007)
-
Volume 1 (2006)
Most Read This Month
Article
content/journals/cds
Journal
10
5
false
en
